OpenURL Connection Search

Select item for more details and to access through your institution.

Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.
Published in:
EMBO Molecular Medicine, 2013, v. 5, n. 8, p. 1180, doi. 10.1002/emmm.201202034
By:
- Emadali, Anouk;
- Rousseaux, Sophie;
- Bruder‐Costa, Juliana;
- Rome, Claire;
- Duley, Samuel;
- Hamaidia, Sieme;
- Betton, Patricia;
- Debernardi, Alexandra;
- Leroux, Dominique;
- Bernay, Benoit;
- Kieffer‐Jaquinod, Sylvie;
- Combes, Florence;
- Ferri, Elena;
- McKenna, Charles E.;
- Petosa, Carlo;
- Bruley, Christophe;
- Garin, Jérôme;
- Ferro, Myriam;
- Gressin, Rémy;
- Callanan, Mary B.
Publication type:
Article
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.
Published in:
PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0158297
By:
- Bruder Costa, Juliana;
- Dufeu-Duchesne, Tania;
- Leroy, Vincent;
- Bertucci, Inga;
- Bouvier-Alias, Magali;
- Pouget, Noelle;
- Brevot-Lutton, Ophelie;
- Bourliere, Marc;
- Zoulim, Fabien;
- Plumas, Joel;
- Aspord, Caroline;
- null, null
Publication type:
Article
Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection.
Published in:
PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0156200
By:
- Aspord, Caroline;
- Bruder Costa, Juliana;
- Jacob, Marie-Christine;
- Dufeu-Duchesne, Tania;
- Bertucci, Inga;
- Pouget, Noelle;
- Brevot-Lutton, Ophelie;
- Zoulim, Fabien;
- Bourliere, Marc;
- Plumas, Joel;
- Leroy, Vincent;
- null, null
Publication type:
Article

Found: 3

Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.

Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.

Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection.